Package 50090-4013-2

{"route": ["ORAL"], "spl_id": "a2bf5a20-39fd-48c0-80fc-97b63b0ed658", "openfda": {"unii": ["V3888OEY5R"], "rxcui": ["897666"], "spl_set_id": ["f00c1caf-68b6-40c1-a1fa-72d17d2cf44f"], "manufacturer_name": ["A-S Medication Solutions"]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (50090-4013-0)", "package_ndc": "50090-4013-0", "marketing_start_date": "20190102"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE (50090-4013-2)", "package_ndc": "50090-4013-2", "marketing_start_date": "20230503"}], "brand_name": "VERAPAMIL HYDROCHLORIDE", "product_id": "50090-4013_a2bf5a20-39fd-48c0-80fc-97b63b0ed658", "dosage_form": "TABLET", "pharm_class": ["Calcium Channel Antagonists [MoA]", "Calcium Channel Blocker [EPC]", "Cytochrome P450 3A Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "product_ndc": "50090-4013", "generic_name": "VERAPAMIL HYDROCHLORIDE", "labeler_name": "A-S Medication Solutions", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "VERAPAMIL HYDROCHLORIDE", "active_ingredients": [{"name": "VERAPAMIL HYDROCHLORIDE", "strength": "120 mg/1"}], "application_number": "ANDA071881", "marketing_category": "ANDA", "marketing_start_date": "20180720", "listing_expiration_date": "20261231"}